NASDAQ:RMTI Rockwell Medical (RMTI) Stock Price, News & Analysis $2.97 -0.13 (-4.19%) (As of 10:47 AM ET) Add Compare Share Share Today's Range$2.93▼$3.1550-Day Range$1.67▼$3.1052-Week Range$1.16▼$3.23Volume166,539 shsAverage Volume211,685 shsMarket Capitalization$92.16 millionP/E RatioN/ADividend YieldN/APrice Target$7.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Rockwell Medical alerts: Email Address Rockwell Medical MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside135.7% Upside$7.00 Price TargetShort InterestHealthy1.64% of Float Sold ShortDividend StrengthN/ASustainability-2.35Upright™ Environmental ScoreNews Sentiment1.16Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.03) to $0.07 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.24 out of 5 starsMedical Sector144th out of 924 stocksPharmaceutical Preparations Industry49th out of 426 stocks 3.5 Analyst's Opinion Consensus RatingRockwell Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageRockwell Medical has only been the subject of 1 research reports in the past 90 days.Read more about Rockwell Medical's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted1.64% of the float of Rockwell Medical has been sold short.Short Interest Ratio / Days to CoverRockwell Medical has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Rockwell Medical has recently decreased by 18.67%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldRockwell Medical does not currently pay a dividend.Dividend GrowthRockwell Medical does not have a long track record of dividend growth. Previous Next 4.1 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreRockwell Medical has received a 58.29% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is false driven by its "Iron deficiency medication" and "Clinical research services for deficiency diseases" products. See details.Environmental SustainabilityThe Environmental Impact score for Rockwell Medical is -2.35. Previous Next 3.4 News and Social Media Coverage News SentimentRockwell Medical has a news sentiment score of 1.16. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.44 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Rockwell Medical this week, compared to 1 article on an average week.Search Interest11 people have searched for RMTI on MarketBeat in the last 30 days. This is an increase of 267% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Rockwell Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Rockwell Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.90% of the stock of Rockwell Medical is held by insiders.Percentage Held by InstitutionsOnly 23.31% of the stock of Rockwell Medical is held by institutions.Read more about Rockwell Medical's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Rockwell Medical are expected to grow in the coming year, from ($0.03) to $0.07 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Rockwell Medical is -8.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Rockwell Medical is -8.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioRockwell Medical has a P/B Ratio of 3.96. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Rockwell Medical's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad WealthPress$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. About Rockwell Medical Stock (NASDAQ:RMTI)Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.Read More RMTI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RMTI Stock News HeadlinesAugust 15, 2024 | americanbankingnews.comHC Wainwright Analysts Raise Earnings Estimates for Rockwell Medical, Inc. (NASDAQ:RMTI)August 15, 2024 | americanbankingnews.comBrokers Set Expectations for Rockwell Medical, Inc.'s Q1 2025 Earnings (NASDAQ:RMTI)August 22, 2024 | Darwin (Ad)Top Stock Unveiled!Ready to discover the standout stock of 2024? We’ve identified a single buy & hold gem that’s poised to redefine your portfolio. Download our exclusive report now and dive into the Insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.August 13, 2024 | americanbankingnews.comHC Wainwright Reaffirms "Buy" Rating for Rockwell Medical (NASDAQ:RMTI)August 12, 2024 | markets.businessinsider.comRockwell Med Secures Buy Rating on Strong Financials and Strategic Growth ProspectsAugust 11, 2024 | finance.yahoo.comRockwell Medical, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This YearAugust 10, 2024 | markets.businessinsider.comMaxim Group Reaffirms Their Buy Rating on Rockwell Med (RMTI)August 9, 2024 | seekingalpha.comRockwell Medical, Inc. (RMTI) Q2 2024 Earnings Call TranscriptAugust 22, 2024 | Darwin (Ad)Top Stock Unveiled!Ready to discover the standout stock of 2024? We’ve identified a single buy & hold gem that’s poised to redefine your portfolio. Download our exclusive report now and dive into the Insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.August 8, 2024 | finance.yahoo.comRockwell Medical Reports Profitability on a Cash Flow and Adjusted EBITDA Basis in the Second Quarter of 2024August 8, 2024 | msn.comRockwell Medical Non-GAAP EPS of $0.05, revenue of $25.83M beats by $2.91MAugust 7, 2024 | markets.businessinsider.comHere's what Wall Street expects from Rockwell Medical's earningsAugust 7, 2024 | stockhouse.comRockwell Medical Launches Convenience Pack to Support Home Hemodialysis and Acute Dialysis FacilitiesAugust 7, 2024 | msn.comRockwell Medical Q2 Earnings PreviewJuly 21, 2024 | seekingalpha.comRockwell Medical Looks Like A Speculative Buy As It Approaches ProfitabilityJuly 9, 2024 | 247wallst.com3 Penny Stocks With 735% Average Upside, According to Wall StreetMay 30, 2024 | businesswire.comRockwell Medical Promotes Tim Chole to Chief Commercial OfficerMay 16, 2024 | markets.businessinsider.comRockwell Medical: Strong Financial Performance and Strategic Partnerships Justify Buy RatingSee More Headlines Receive RMTI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Rockwell Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/08/2024Today8/22/2024Next Earnings (Estimated)11/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryHealth Care Equipment Current SymbolNASDAQ:RMTI CUSIP77437410 CIK1041024 Webwww.rockwellmed.com Phone(248) 432-1362Fax248-960-9119Employees300Year Founded1995Price Target and Rating Average Stock Price Target$7.00 High Stock Price Target$9.00 Low Stock Price Target$5.00 Potential Upside/Downside+125.8%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.36) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,440,000.00 Net Margins-5.06% Pretax Margin-5.06% Return on Equity-6.96% Return on Assets-2.90% Debt Debt-to-Equity Ratio0.41 Current Ratio2.00 Quick Ratio1.60 Sales & Book Value Annual Sales$83.61 million Price / Sales1.15 Cash Flow$0.02 per share Price / Cash Flow132.92 Book Value$0.75 per share Price / Book4.13Miscellaneous Outstanding Shares31,030,000Free Float29,740,000Market Cap$96.19 million OptionableOptionable Beta1.43 Social Links 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report Key ExecutivesDr. Mark Strobeck Ph.D. (Age 53)President, CEO & Director Comp: $904.66kMr. Jesse Neri (Age 46)Senior Vice President of Finance Comp: $359.63kMs. Megan C. Timmins (Age 51)Executive VP, Chief Legal Officer & Secretary Comp: $585.74kMr. James A. McCarthySenior Vice President of Business & Corporate DevelopmentMr. Timothy T. CholeSenior Vice President of Sales & MarketingMs. Heather R. HunterSenior VP & Chief Corporate Affairs OfficerMr. Jason FinkelsteinInvestor Relations RepresentativeMore ExecutivesKey CompetitorsFONARNASDAQ:FONRIRIDEXNASDAQ:IRIXEdap TmsNASDAQ:EDAPAngioDynamicsNASDAQ:ANGOAccurayNASDAQ:ARAYView All CompetitorsInstitutional OwnershipArmistice Capital LLCBought 592,000 shares on 8/15/2024Ownership: 10.627%Richmond Brothers Inc.Sold 45,423 shares on 8/12/2024Ownership: 0.913%XTX Topco LtdSold 12,871 shares on 8/12/2024Ownership: 0.064%Renaissance Technologies LLCBought 92,189 shares on 8/9/2024Ownership: 0.339%View All Institutional Transactions RMTI Stock Analysis - Frequently Asked Questions How have RMTI shares performed this year? Rockwell Medical's stock was trading at $1.89 at the start of the year. Since then, RMTI shares have increased by 57.1% and is now trading at $2.97. View the best growth stocks for 2024 here. How were Rockwell Medical's earnings last quarter? Rockwell Medical, Inc. (NASDAQ:RMTI) issued its quarterly earnings results on Thursday, August, 8th. The company reported $0.01 EPS for the quarter, beating the consensus estimate of ($0.04) by $0.05. The company earned $25.83 million during the quarter, compared to the consensus estimate of $23.01 million. Rockwell Medical had a negative net margin of 5.06% and a negative trailing twelve-month return on equity of 6.96%. When did Rockwell Medical's stock split? Shares of Rockwell Medical reverse split on Friday, May 13th 2022. The 1-11 reverse split was announced on Friday, May 13th 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 13th 2022. An investor that had 100 shares of stock prior to the reverse split would have 9 shares after the split. What is Robert L. Chioini's approval rating as Rockwell Medical's CEO? 6 employees have rated Rockwell Medical Chief Executive Officer Robert L. Chioini on Glassdoor.com. Robert L. Chioini has an approval rating of 22% among the company's employees. This puts Robert L. Chioini in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. Who are Rockwell Medical's major shareholders? Rockwell Medical's top institutional shareholders include Armistice Capital LLC (10.63%), Richmond Brothers Inc. (0.91%), Renaissance Technologies LLC (0.34%) and XTX Topco Ltd (0.06%). View institutional ownership trends. How do I buy shares of Rockwell Medical? Shares of RMTI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Rockwell Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Rockwell Medical investors own include Immunomedics (IMMU), JinkoSolar (JKS), Seagen (SGEN), Geron (GERN), OPKO Health (OPK), Amarin (AMRN) and Gilead Sciences (GILD). This page (NASDAQ:RMTI) was last updated on 8/22/2024 by MarketBeat.com Staff From Our PartnersWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredAir Force quietly working with sub $10 stock on new techThere is a little-known energy technology stock that has made an incredible breakthrough… Which could becom...DTI | SponsoredTrump is sounding the alarmEurope is one of the latest to release a central bank digital currency and along with it, new cash rules. Chri...Preserve Gold | SponsoredUS developing “superweapon” to defeat China and Russia?Our new superweapon is a gift to every patriot. I predict the devastating new tech behind this weapon will cre...Paradigm Press | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredAmazon coin set to soar 25X – starting August 19thChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | Sponsored625,000% GainThe recent crypto pullback has been brutal, causing widespread panic among investors. But for us, it’s just an...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rockwell Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rockwell Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
